Featured Research

from universities, journals, and other organizations

Are Scientists Making Progress In Being Able To Regenerate Bone Tissue?

Date:
February 20, 2007
Source:
Public Library of Science
Summary:
In an article in PLoS Medicine, Gert Meijer (University Medical Centre Utrecht, the Netherlands) and colleagues discuss what kind of progress there has been in restoring the function of diseased or damaged bone by bone tissue regeneration.

In an article in PLoS Medicine, Gert Meijer (University Medical Centre Utrecht, The Netherlands) and colleagues discuss what kind of progress there has been in restoring the function of diseased or damaged bone by bone tissue regeneration.

Until recently, say the authors, the use of bone grafts from a different part of the patient's own body has been the number one choice for attempting to restore function. But there are major problems with such grafts--for example, removing bone from a different part of the body can lead to post-operative pain, infection, and abnormal sensations at the removal site. An alternative is to use bone given by a donor--but such bone grafts from donors are less successful and there is a risk of transmitting viruses from the donor to the recipient.

Given all these problems with bone grafts, scientists have attempted to engineer bone tissue. "Bone tissue engineering using bone marrow stem cells has been suggested as a promising technique for reconstructing bone defects," say Meijer and colleagues. Bone tissue engineering has shown success in animal studies.

In their article the authors review the available data on bone tissue engineering in human studies, including clinical research they themselves have conducted. They also discuss possible new directions that need to be exploited to make bone tissue engineering a clinical success.

Citation: Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA (2007) Cell-based bone tissue engineering. PLoS Med 4(2): e9. (http://dx.doi.org/10.1371/journal.pmed.0040009)


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Cite This Page:

Public Library of Science. "Are Scientists Making Progress In Being Able To Regenerate Bone Tissue?." ScienceDaily. ScienceDaily, 20 February 2007. <www.sciencedaily.com/releases/2007/02/070220020817.htm>.
Public Library of Science. (2007, February 20). Are Scientists Making Progress In Being Able To Regenerate Bone Tissue?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/02/070220020817.htm
Public Library of Science. "Are Scientists Making Progress In Being Able To Regenerate Bone Tissue?." ScienceDaily. www.sciencedaily.com/releases/2007/02/070220020817.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins